Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon

PURPOSE: Outcomes in pediatric osteosarcoma have dramatically improved over the past few decades, with overall survival rates of 70% and 30% for patients with localized and metastatic disease, respectively. PATIENTS AND METHODS: We retrospectively reviewed clinical characteristics and outcomes of 38...

Full description

Bibliographic Details
Main Authors: Bilal Abou Ali, Mayssa Salman, Khaled M. Ghanem, Fouad Boulos, Rachid Haidar, Said Saghieh, Samir Akel, Samar A. Muwakkit, Hassan El-Solh, Raya Saab, Hani Tamim, Miguel R. Abboud
Format: Article
Language:English
Published: American Society of Clinical Oncology 2019-04-01
Series:Journal of Global Oncology
Online Access:http://ascopubs.org/doi/10.1200/JGO.17.00241
id doaj-6c0349cbd08c49aab18ed975b4c244b7
record_format Article
spelling doaj-6c0349cbd08c49aab18ed975b4c244b72020-11-25T03:34:15ZengAmerican Society of Clinical OncologyJournal of Global Oncology2378-95062019-04-0151810.1200/JGO.17.002411Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in LebanonBilal Abou Ali0Mayssa Salman1Khaled M. Ghanem2Fouad Boulos3Rachid Haidar4Said Saghieh5Samir Akel6Samar A. Muwakkit7Hassan El-Solh8Raya Saab9Hani Tamim10Miguel R. Abboud11Children's Cancer Institute, American University of Beirut, Beirut, LebanonChildren's Cancer Institute, American University of Beirut, Beirut, LebanonChildren's Cancer Institute, American University of Beirut, Beirut, LebanonChildren's Cancer Institute, American University of Beirut, Beirut, LebanonChildren's Cancer Institute, American University of Beirut, Beirut, LebanonChildren's Cancer Institute, American University of Beirut, Beirut, LebanonChildren's Cancer Institute, American University of Beirut, Beirut, LebanonChildren's Cancer Institute, American University of Beirut, Beirut, LebanonChildren's Cancer Institute, American University of Beirut, Beirut, LebanonChildren's Cancer Institute, American University of Beirut, Beirut, LebanonChildren's Cancer Institute, American University of Beirut, Beirut, LebanonChildren's Cancer Institute, American University of Beirut, Beirut, LebanonPURPOSE: Outcomes in pediatric osteosarcoma have dramatically improved over the past few decades, with overall survival rates of 70% and 30% for patients with localized and metastatic disease, respectively. PATIENTS AND METHODS: We retrospectively reviewed clinical characteristics and outcomes of 38 patients treated between 2001 and 2012 at a single institution in Lebanon. All patients received a uniform three-drug chemotherapy regimen consisting of cisplatin, doxorubicin, and methotrexate. Ifosfamide and etoposide were added to the adjuvant treatment regimen in case of metastatic disease and/or poor degree of tumor necrosis (< 90%). RESULTS: After a median follow-up of 61 months (range, 8 to 142 months), patients with localized disease had 5-year overall and event-free survival rates of approximately 81% and 68%, respectively, whereas for metastatic disease, they were approximately 42%. The most common primary site was the long bones around the knee (n = 34; 89.5%). Six patients (15.8%) had metastatic disease to lungs, and three (7.9%) had synchronous multifocal bone disease with lung metastases. Adverse prognostic factors included nonlower extremity sites, metastasis, poor degree of necrosis, and delay of more than 4 weeks in local control. In bivariable analysis, only degree of necrosis was a prognostic predictor for survival and disease recurrence. CONCLUSION: Treatment of pediatric osteosarcoma in a multidisciplinary cancer center in Lebanon resulted in survival similar to that in developed countries. Delay in local control was associated with worse outcome. The only statistically significant inferior outcome predictor was poor degree of necrosis at the time of local control.http://ascopubs.org/doi/10.1200/JGO.17.00241
collection DOAJ
language English
format Article
sources DOAJ
author Bilal Abou Ali
Mayssa Salman
Khaled M. Ghanem
Fouad Boulos
Rachid Haidar
Said Saghieh
Samir Akel
Samar A. Muwakkit
Hassan El-Solh
Raya Saab
Hani Tamim
Miguel R. Abboud
spellingShingle Bilal Abou Ali
Mayssa Salman
Khaled M. Ghanem
Fouad Boulos
Rachid Haidar
Said Saghieh
Samir Akel
Samar A. Muwakkit
Hassan El-Solh
Raya Saab
Hani Tamim
Miguel R. Abboud
Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon
Journal of Global Oncology
author_facet Bilal Abou Ali
Mayssa Salman
Khaled M. Ghanem
Fouad Boulos
Rachid Haidar
Said Saghieh
Samir Akel
Samar A. Muwakkit
Hassan El-Solh
Raya Saab
Hani Tamim
Miguel R. Abboud
author_sort Bilal Abou Ali
title Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon
title_short Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon
title_full Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon
title_fullStr Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon
title_full_unstemmed Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon
title_sort clinical prognostic factors and outcome in pediatric osteosarcoma: effect of delay in local control and degree of necrosis in a multidisciplinary setting in lebanon
publisher American Society of Clinical Oncology
series Journal of Global Oncology
issn 2378-9506
publishDate 2019-04-01
description PURPOSE: Outcomes in pediatric osteosarcoma have dramatically improved over the past few decades, with overall survival rates of 70% and 30% for patients with localized and metastatic disease, respectively. PATIENTS AND METHODS: We retrospectively reviewed clinical characteristics and outcomes of 38 patients treated between 2001 and 2012 at a single institution in Lebanon. All patients received a uniform three-drug chemotherapy regimen consisting of cisplatin, doxorubicin, and methotrexate. Ifosfamide and etoposide were added to the adjuvant treatment regimen in case of metastatic disease and/or poor degree of tumor necrosis (< 90%). RESULTS: After a median follow-up of 61 months (range, 8 to 142 months), patients with localized disease had 5-year overall and event-free survival rates of approximately 81% and 68%, respectively, whereas for metastatic disease, they were approximately 42%. The most common primary site was the long bones around the knee (n = 34; 89.5%). Six patients (15.8%) had metastatic disease to lungs, and three (7.9%) had synchronous multifocal bone disease with lung metastases. Adverse prognostic factors included nonlower extremity sites, metastasis, poor degree of necrosis, and delay of more than 4 weeks in local control. In bivariable analysis, only degree of necrosis was a prognostic predictor for survival and disease recurrence. CONCLUSION: Treatment of pediatric osteosarcoma in a multidisciplinary cancer center in Lebanon resulted in survival similar to that in developed countries. Delay in local control was associated with worse outcome. The only statistically significant inferior outcome predictor was poor degree of necrosis at the time of local control.
url http://ascopubs.org/doi/10.1200/JGO.17.00241
work_keys_str_mv AT bilalabouali clinicalprognosticfactorsandoutcomeinpediatricosteosarcomaeffectofdelayinlocalcontrolanddegreeofnecrosisinamultidisciplinarysettinginlebanon
AT mayssasalman clinicalprognosticfactorsandoutcomeinpediatricosteosarcomaeffectofdelayinlocalcontrolanddegreeofnecrosisinamultidisciplinarysettinginlebanon
AT khaledmghanem clinicalprognosticfactorsandoutcomeinpediatricosteosarcomaeffectofdelayinlocalcontrolanddegreeofnecrosisinamultidisciplinarysettinginlebanon
AT fouadboulos clinicalprognosticfactorsandoutcomeinpediatricosteosarcomaeffectofdelayinlocalcontrolanddegreeofnecrosisinamultidisciplinarysettinginlebanon
AT rachidhaidar clinicalprognosticfactorsandoutcomeinpediatricosteosarcomaeffectofdelayinlocalcontrolanddegreeofnecrosisinamultidisciplinarysettinginlebanon
AT saidsaghieh clinicalprognosticfactorsandoutcomeinpediatricosteosarcomaeffectofdelayinlocalcontrolanddegreeofnecrosisinamultidisciplinarysettinginlebanon
AT samirakel clinicalprognosticfactorsandoutcomeinpediatricosteosarcomaeffectofdelayinlocalcontrolanddegreeofnecrosisinamultidisciplinarysettinginlebanon
AT samaramuwakkit clinicalprognosticfactorsandoutcomeinpediatricosteosarcomaeffectofdelayinlocalcontrolanddegreeofnecrosisinamultidisciplinarysettinginlebanon
AT hassanelsolh clinicalprognosticfactorsandoutcomeinpediatricosteosarcomaeffectofdelayinlocalcontrolanddegreeofnecrosisinamultidisciplinarysettinginlebanon
AT rayasaab clinicalprognosticfactorsandoutcomeinpediatricosteosarcomaeffectofdelayinlocalcontrolanddegreeofnecrosisinamultidisciplinarysettinginlebanon
AT hanitamim clinicalprognosticfactorsandoutcomeinpediatricosteosarcomaeffectofdelayinlocalcontrolanddegreeofnecrosisinamultidisciplinarysettinginlebanon
AT miguelrabboud clinicalprognosticfactorsandoutcomeinpediatricosteosarcomaeffectofdelayinlocalcontrolanddegreeofnecrosisinamultidisciplinarysettinginlebanon
_version_ 1724559761035231232